The Centre for Cellular & Molecular Biology (CCMB) and Aganitha, a new generation 'in silico' solutions provider, signed a framework agreement to apply Generative Artificial Intelligence (AI) solutions for designing novel therapeutics and .
Managing costs is tricky for companies because the pay-as-you-go model can get expensive with high usage, while minimum payment models need a huge upfront commitment